SCHEMBL2992005

SCHEMBL2992005

COC(=O)Cc1ccc(Oc2ccc(NC(=O)c3ccc(Cl)c(Cl)c3)cc2)c(CN)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
HTR2A P28223 2/20 0.47
SLC6A4 P31645 2/20 0.47
BCAT2 O15382 1/20 0.46
MAPT P10636 2/20 0.45
LMNA P02545 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PKM P14618 1/20 0.44
PTGDR2 Q9Y5Y4 2/20 0.44
CCR2 P41597 3/20 0.43
KCNH2 Q12809 1/20 0.43
ROCK2 O75116 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
TAS1R2 Q8TE23 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2994986 0.91 KDM4E (0.47) KDM4ESMN1; SMN2NPC1RAB9AHTR2A
SCHEMBL2985399 0.84 SMN1; SMN2 (0.46) KDM4ESMN1; SMN2NPC1RAB9AHTR2A
SCHEMBL2975299 0.81 MEN1 (0.47) KDM4ESMN1; SMN2NPC1RAB9AMAPT
SCHEMBL2989737 0.81 KDM4E (0.60) KDM4EHTR2ASLC6A4LMNAPTGDR2
SCHEMBL13742112 0.80 KDM4E (0.50) KDM4ESMN1; SMN2NPC1RAB9AMAPT
SCHEMBL14301343 0.80 KDM4E (0.50) KDM4ENPC1RAB9AHTR2ASLC6A4
SCHEMBL2991646 0.79 KDM4E (0.60) KDM4ENPC1RAB9AHTR2ASLC6A4
SCHEMBL2981115 0.79 KDM4E (0.66) KDM4ERAB9AMAPTLMNAMEN1
SCHEMBL13742651 0.79 KDM4E (0.72) KDM4ENPC1RAB9ABCAT2MAPT
SCHEMBL13742574 0.78 KDM4E (0.50) KDM4ESMN1; SMN2NPC1RAB9ABCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 US disclosed
EP-2057115-B9 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-12-26 EP disclosed
EP-2057115-B1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-10-03 EP disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 US disclosed
US-8183289-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2012-05-22 US disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 US disclosed
EP-2057115-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2009-05-13 EP disclosed
WO-2008024746-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA, INC. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 KDM4E 1078/4885SMN1; SMN2 3361/4885NPC1 3905/4885
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 KDM4E 1078/4885SMN1; SMN2 3361/4885NPC1 3905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.